Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 133

Sort by

Sort Order Select

Journal Articles

Adaptive rebalancing of ROS composition averts LSD1 inhibitor–induced oxidative stress in AML

Dharmendra Kashyap, Cihangir Duy, Manna Ahmed, Alexander Vartanov, Martin Carroll, Kerry Campbell, Yuliya Shestovska, William Rainow, Anne E Ojala

Blood (2025) 146 (Supplement 1): 5070.

https://doi.org/10.1182/blood-2025-5070

Published: 2025

Journal Articles

Inflammatory and metabolic gene signatures predict overall survival and response to venetoclax-based therapy in TP53 mutant AML

Sarah Skuli, Jayakumar Vadakekolathu, Elena Fenu, Kate Bennett, Jem Palma, Jaryse Harris, Olivia Leung, Eesha Balar, Olga Pozdnyakova, Adam Bagg, Andrew Matthews, Martin Carroll, Catherine Lai, Sergio Rutella

Blood (2025) 146 (Supplement 1): 1734.

https://doi.org/10.1182/blood-2025-1734

Published: 2025

Journal Articles

Tumor-induced dendritic cell dysfunction impairs T-cell proliferation and confers poor prognosis in high-risk acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 5138.

https://doi.org/10.1182/blood-2025-5138

Published: 2025

Journal Articles

T cell receptors targeting mutant NPM1 for adoptive cell therapy in acute myeloid leukemia

Aidan Pursley, Amanda Chen, Zhiya Yu, Catherine Ade, Ken-ichi Hanada, Peter Aplan, Martin Carroll, James Yang, Steven Pavletic, Vid Leko

Blood (2025) 146 (Supplement 1): 4132.

https://doi.org/10.1182/blood-2025-4132

Published: 2025

Journal Articles

Acute Myeloid Leukemia: Diagnosis and treatment at a tertiary center in cochabamba - Bolivia.

Veronica Campuzano Saavedra, Cristian Rodrigo Lazo, Yelitza Muñoz, Martin Carroll, Claudia Telleria, Carlos Aguilar-Franco, Jose Macias Abasto, Ximena Jordan Bruno

Blood (2025) 146 (Supplement 1): 6929.

https://doi.org/10.1182/blood-2025-6929

Published: 2025

Journal Articles

Longitudinal genomic and cytogenetic dynamics in myelodysplastic syndromes (MDS): Insights into clonal evolution and disease progression

Varsha Singh, Rebecca Ramesh, Eesha Balar, Priya Velu, Roopsha Bandopadhyay, Michael Bowman, Safoora Deihimi, Jonathan Belman, Selina Luger, Andrew Matthews, Martin Carroll, Jennifer Morrissette, Sarah Skuli, Robert Bowman

Blood (2025) 146 (Supplement 1): 5635.

https://doi.org/10.1182/blood-2025-5635

Published: 2025

Journal Articles

Mapping the Cellular Biogeography of Human Bone Marrow Niches Using Single-Cell Transcriptomics and Proteomic Imaging

Blood (2023) 142 (Supplement 1): 4072.

https://doi.org/10.1182/blood-2023-179280

Published: 2023

Journal Articles

Comparing Cairo Bishop and Howard Criteria for Identifying Clinically Meaningful Tumor Lysis Syndrome Among Acute Myeloid Leukemia Patients Treated with Venetoclax and Hypomethylating Agents: A Single Center Experience

Blood (2023) 142 (Supplement 1): 5095.

https://doi.org/10.1182/blood-2023-186978

Published: 2023

Journal Articles

Minimal Residual Disease in Acute Myeloid Leukemia Following Induction Chemotherapy Can be Effectively Eradicated By Targeting Mitochondrial Metabolism

Blood (2023) 142 (Supplement 1): 2952.

https://doi.org/10.1182/blood-2023-186514

Published: 2023

Journal Articles

The Mevalonate Pathway Is a Therapeutic Target in TP53 Mutant Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 408.

https://doi.org/10.1182/blood-2023-185059

Published: 2023

Journal Articles

Loss of CCAAT‐Enhancer Binding Protein Delta Promotes Acute Myeloid Leukemia Cell Proliferation and Survival By Upregulating Cyclin D1 Expression

Blood (2023) 142 (Supplement 1): 1380.

https://doi.org/10.1182/blood-2023-181946

Published: 2023

Journal Articles

Transcriptomic without Clinical Response to Menin Inhibition As a Mechanism of Upfront Resistance in Samples from Mutliply Relapsed Patients with KMT2A-Rearranged Leukemia

Leila Mahdavi, Haley Goodrow, Hongbo Xie, Alexandra Lenard, Fatemeh Alikarami, Simone Stefanie Riedel, Sarah K. Tasian, Gerald Wertheim, Sarah Skuli, Martin Carroll, Jerry McGeehan, Kathrin M. Bernt

Blood (2023) 142 (Supplement 1): 4166.

https://doi.org/10.1182/blood-2023-180967

Published: 2023

Journal Articles

Serum Amyloid A1 (SAA1) Secreted By the Stromal Microenvironment Drives Malignant Clonal Proliferation in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Brian Chernak, Marta Galan-Diez, Abdullah Mahmood Ali, Alvaro Cuesta-Dominguez, Ziwei Chen, Thomas Koehnke, Ravindra Majeti, Martin Carroll, Azra Raza, Stavroula Kousteni

Blood (2023) 142 (Supplement 1): 4118.

https://doi.org/10.1182/blood-2023-174485

Published: 2023

Journal Articles

NAMPT Haploinsufficiency Is a Therapeutic Vulnerability in High-Risk Myeloid Malignancies

Madhavi D. Senagolage, Saira Khan, Sarah Skuli, Martin Carroll, Megan E. McNerney

Blood (2023) 142 (Supplement 1): 5753.

https://doi.org/10.1182/blood-2023-191061

Published: 2023

Journal Articles

Somatic Mutation Screening in Adult Patients with Myeloid Malignancies Provides Insights into Likely Germline Variants

Rahul S. Bhansali, Xin Wang, Valentina Mattfeld, Dana F. Clark, Jennifer JD Morrissette, Martin Carroll, Daria Babushok, Ximena Jordan Bruno

Blood (2023) 142 (Supplement 1): 5665.

https://doi.org/10.1182/blood-2023-174488

Published: 2023

Journal Articles

Developing a Humanized Murine Model for Co-Transplantation of Acute Myeloid Leukemia

Ding-Wen Chen, Tingting Huang, Yuyang Huang, Stephanie N Hurwitz, Julie Schrey, Jian-Meng Fan, Martin Carroll, Peter Kurre, Bonnie W Lau

Blood (2022) 140 (Supplement 1): 5776–5777.

https://doi.org/10.1182/blood-2022-158615

Published: 2022

Journal Articles

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

Caroline Duault, Anil Kumar, Adeleh Taghi Khani, Sung June Lee, Lu Yang, Min Huang, Christian Hurtz, Bryan Manning, Lucy Ghoda, Tinisha McDonald, Norman J. Lacayo, Kathleen M. Sakamoto, Martin Carroll, Sarah K. Tasian, Guido Marcucci, Jianhua Yu, Michael A. Caligiuri, Holden T. Maecker, Srividya Swaminathan

Blood (2021) 138 (16): 1465–1480.

https://doi.org/10.1182/blood.2020009871

Published: 2021

Includes: Supplemental data

Journal Articles

BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells

Kimihito C. Kawabata, Hongliang Zong, Cem Meydan, Sarah Wyman, Bas J. Wouters, Mayumi Sugita, Srinjoy Goswami, Michael Albert, Winnie Yip, Gail J. Roboz, Zhengming Chen, Ruud Delwel, Martin Carroll, Christopher E. Mason, Ari Melnick, Monica L. Guzman

Blood (2021) 137 (6): 812–825.

https://doi.org/10.1182/blood.2019001745

Published: 2021

Includes: Supplemental data

Journal Articles

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

Blood (2020) 136 (6): 698–714.

https://doi.org/10.1182/blood.2019003062

Published: 2020

Includes: Supplemental data

Journal Articles

A common protein target for an uncommon subtype of AML

Martin Carroll

Blood (2020) 136 (4): 377–378.

https://doi.org/10.1182/blood.2020006487

Published: 2020

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Adaptive rebalancing of ROS composition averts LSD1 inhibitor–induced oxidative stress in AML

Inflammatory and metabolic gene signatures predict overall survival and response to venetoclax-based therapy in TP53 mutant AML

Tumor-induced dendritic cell dysfunction impairs T-cell proliferation and confers poor prognosis in high-risk acute lymphoblastic leukemia

T cell receptors targeting mutant NPM1 for adoptive cell therapy in acute myeloid leukemia

Acute Myeloid Leukemia: Diagnosis and treatment at a tertiary center in cochabamba - Bolivia.

Longitudinal genomic and cytogenetic dynamics in myelodysplastic syndromes (MDS): Insights into clonal evolution and disease progression

Mapping the Cellular Biogeography of Human Bone Marrow Niches Using Single-Cell Transcriptomics and Proteomic Imaging

Comparing Cairo Bishop and Howard Criteria for Identifying Clinically Meaningful Tumor Lysis Syndrome Among Acute Myeloid Leukemia Patients Treated with Venetoclax and Hypomethylating Agents: A Single Center Experience

Minimal Residual Disease in Acute Myeloid Leukemia Following Induction Chemotherapy Can be Effectively Eradicated By Targeting Mitochondrial Metabolism

The Mevalonate Pathway Is a Therapeutic Target in TP53 Mutant Acute Myeloid Leukemia

Loss of CCAAT‐Enhancer Binding Protein Delta Promotes Acute Myeloid Leukemia Cell Proliferation and Survival By Upregulating Cyclin D1 Expression

Transcriptomic without Clinical Response to Menin Inhibition As a Mechanism of Upfront Resistance in Samples from Mutliply Relapsed Patients with KMT2A-Rearranged Leukemia

Serum Amyloid A1 (SAA1) Secreted By the Stromal Microenvironment Drives Malignant Clonal Proliferation in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

NAMPT Haploinsufficiency Is a Therapeutic Vulnerability in High-Risk Myeloid Malignancies

Somatic Mutation Screening in Adult Patients with Myeloid Malignancies Provides Insights into Likely Germline Variants

Developing a Humanized Murine Model for Co-Transplantation of Acute Myeloid Leukemia

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia

BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

A common protein target for an uncommon subtype of AML

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only